UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein

Clark, RE; Dodi, IA; Hill, SC; Lill, JR; Aubert, G; Macintyre, AR; Rojas, J; ... Madrigal, JA; + view all (2001) Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood , 98 (10) pp. 2887-2893. Green open access

[thumbnail of 6966.pdf]
Preview
PDF
6966.pdf

Download (236kB)

Abstract

The BCR-ABL oncogene is central in the pathogenesis of chronic myeloid leukemia (CML). Here, tandem nanospray mass spectrometry was used to demonstrate cell surface HLA- associated expression of the BCR-ABL peptide KQSSKALQR on class I-negative CIVIL cells transfected with HLA-A*0301, and on primary CIVIL cells from HLA-A3-positive patients. These patients mounted a cytotoxic T-lymphocyte response to KQSSKALQR that also killed autologous CML cells, and tetramer staining demonstrated the presence of circulating KQSSKALQR-specific T cells. The findings are the first demonstration that CML cells express HLA-associated leukemia-specific immunogenic peptides and provide a sound basis for immunization studies against BCR- ABL. (C) 2001 by The American Society of Hematology

Type: Article
Title: Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein
Open access status: An open access version is available from UCL Discovery
Additional information: Journal English Article AMER SOC HEMATOLOGY NOV 15 492PW WASHINGTON BLOOD 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
Keywords: American, autologous, BCR-ABL, BCR-ABL ONCOGENE, Blood, cell, Cell Surface, CELL-SURFACE, CELLS, Chronic, CHRONIC MYELOGENOUS LEUKEMIA, CHRONIC MYELOID-LEUKEMIA, circulating, Class, CLASS-I MOLECULES, CML, cytotoxic T lymphocyte, CYTOTOXIC T-LYMPHOCYTES, Dendritic Cells, English, Epitopes, expression, FUSION, FUSION PROTEIN, Hematology, HLA, Immunization, Leukemia, LIFE, M, MASS, Mass Spectrometry, MASS-SPECTROMETRY, MYELOID-LEUKEMIA, NORMAL DONORS, ONCOGENE, PATHOGENESIS, Patient, patients, peptide, Peptides, PERIPHERAL-BLOOD, PHILADELPHIA-CHROMOSOME, PHYS, PROTEIN, response, societies, SOCIETY, sound, SPECTROMETRY, SPONTANEOUS REMISSION, Staining, SURFACE, T cell, T CELLS, T lymphocyte, T-CELL, T-CELLS, USA
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
URI: https://discovery-pp.ucl.ac.uk/id/eprint/6966
Downloads since deposit
56,392Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item